514 related articles for article (PubMed ID: 18450803)
21. Factors influencing oral colonization in premature infants.
Makhoul IR; Sujov P; Ardekian L; Kassis I; Smolkin T; Abu-Elnaa'j I; Tamir A; Laufer D
Isr Med Assoc J; 2002 Feb; 4(2):98-102. PubMed ID: 11876001
[TBL] [Abstract][Full Text] [Related]
22. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of gentamicin by interval and intravenous dosage adjustment based on the gestational age in Thai neonates.
Tantiprabha W; Juntarakana S; Chotinaruemol S; Rojanasthien N
J Med Assoc Thai; 2007 Dec; 90(12):2601-7. PubMed ID: 18386709
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Arnell K; Enblad P; Wester T; Sjölin J
J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
[TBL] [Abstract][Full Text] [Related]
27. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis.
Chowdhary G; Dutta S; Narang A
J Trop Pediatr; 2006 Dec; 52(6):427-32. PubMed ID: 17030532
[TBL] [Abstract][Full Text] [Related]
28. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin pharmacokinetics and dosing in premature neonates.
McDougal A; Ling EW; Levine M
Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
[TBL] [Abstract][Full Text] [Related]
30. Shortening the antibiotic course for the treatment of neonatal coagulase-negative staphylococcal sepsis: fine with three days?
Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
Neonatology; 2012; 101(2):101-5. PubMed ID: 21934336
[TBL] [Abstract][Full Text] [Related]
31. Neonatal vancomycin continuous infusion: still a confusion?
Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
[TBL] [Abstract][Full Text] [Related]
32. Features of invasive staphylococcal disease in neonates.
Healy CM; Palazzi DL; Edwards MS; Campbell JR; Baker CJ
Pediatrics; 2004 Oct; 114(4):953-61. PubMed ID: 15466090
[TBL] [Abstract][Full Text] [Related]
33. Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates.
Kiatchoosakun P; Kosalaraksa P; Jirapradittha J; Taksaphan S; Tassniyom S
J Med Assoc Thai; 2005 Jul; 88(7):934-8. PubMed ID: 16241022
[TBL] [Abstract][Full Text] [Related]
34. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
35. Leuconostoc septicemia in a preterm neonate on vancomycin therapy: case report and literature review.
Janow G; Lambert B; Scheiner M; Rosen O; Goldman DL; Soghier L
Am J Perinatol; 2009 Jan; 26(1):89-91. PubMed ID: 19031357
[TBL] [Abstract][Full Text] [Related]
36. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
37. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy.
Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
Neonatology; 2011; 100(2):180-5. PubMed ID: 21455008
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
Del Pozo JL; García Cenoz M; Hernáez S; Martínez A; Serrera A; Aguinaga A; Alonso M; Leiva J
Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
